Back to programme
Mon 20 Oct 25 14:30-16:00
SCS
Future vaccination strategies - PART 1 SCS03
Auditorium 1 - Plenary Hall
Chairs
Florian KRAMMER
ESWI Board Member, Medical University of Vienna, Austria
Read more
Yona TUGG
McMaster University, Canada
Read more
Ended Now live Upcoming
  1. Opening of the session
    Florian KRAMMERESWI Board Member, Medical University of Vienna, Austria
    Yona TUGGMcMaster University, Canada
  2. 1. A Dendritic Cell-targeting Approach to Deliver a Universal Influenza Vaccine Candidate to the Respiratory Mucosa
    Daryl LEENational University of Singapore, Singapore
  3. 2. Development of a next-generation COVID-19 intranasal vaccine based on a multivalent NDV-HXP-S formulation.
    Marta BOZA CUENCAIcahn School of Medicine at Mount Sinai, United States
  4. 3. Superior protection and prevention of transmission upon influenza infection by adjuvanted mucosal vaccination in the guinea pig influenza model.
    Michael SCHOTSAERTIcahn School of Medicine at Mount Sinai, United States
  5. 4. Broad betacoronavirus immunity and SARS-CoV-2 protection induced by divergent spike-based nucleoside-modified vaccines
    Anass ABBADIcahn Medical School at Mount Sinai, United States
  6. 5. The Additive Effect of Neuraminidase Inclusion in Influenza Vaccine Formulations using a Self-Amplifying RNA Platform
    Giuseppe PALLADINOCSL, United States
  7. 6. Evaluation of a broadly protective influenza B virus vaccine based on mosaic hemagglutinin platforms in mice.
    Irene GONZÁLEZ-DOMÍNGUEZIcahn School of Medicine at Mount Sinai, United States
  8. Closing remarks
    Florian KRAMMERESWI Board Member, Medical University of Vienna, Austria
    Yona TUGGMcMaster University, Canada